CASE A 51-year-old woman with history of DLE, deep vein thrombosis, and hypothyroidism presented with progressive facial hyperpigmentation of one-year duration that had not been treated
For patients with type 2 diabetes, this can result in inadequate glycemic control, with blood glucose levels rising above target ranges
Typically, the governments approach has been to work with companies to address non-compliance
There's no published evidence supporting this approach over standard 4-week titration intervals, but it's a clinical judgment call within a provider's scope
New 'Triple G' Retatrutide ('Reta') Weight Loss Drug Shows 'Insane' Results It protects heart health The American Heart Association and American Stroke Association now recommend that healthcare professionals consider GLP-1 drugs to reduce stroke risk for certain patients
Another study, not yet published, is SURMOUNT-OSA, a clinical trial of 52-weeks that examined the efficacy and safety of TZP versus placebo in obese participants and an established OSA diagnosis for treatment of moderate and severe OSA (102)